Packaging & Security | Issue 18 | October 2012

While the US has adopted the FDA Safety and Innovation Act to battle counterfeit drugs, the EU has rejected the controversial Anti- Counterfeiting Trade Agreement. In the next issue we discuss the different regulatory approaches and ask what steps are being taken to protect patients and safeguard profits.

We also profile the most promising innovations in packaging to protect pharmaceuticals, such as 2D codes, RFID, DNA authentication and sophisticated tracking software, as well as looking beyond packaging to find out what other measures the industry can take to tackle the counterfeit problem.

Moreover, we find also review technological trends and legislative developments that can aid manufacturers to win the fight against pharmaceutical counterfeiting.

Read the latest issue here.

In This Issue

Gaining Ground
While the US has just adopted the FDA Safety and Innovation Act to battle counterfeit pharmaceuticals, the EU has rejected the controversial Anti-Counterfeiting Trade Agreement (ACTA), which is now feared to boost the online trade of generic and counterfeit medicines. In this feature, we discuss the two different regulatory approaches and ask what steps are implemented in both countries to increase pharmaceutical efficiency, and ensure patient safety and industry operations.
Click here to read the full article.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

A Battle On All Fronts
Reviewing technological trends and legislative development, Dr Jérôme Freissmuth of Bosch packaging technology explains how manufacturers can help win the fight against pharmaceutical counterfeiting.
Click here to read the full article.

Tackling Counterfeits
The pharmaceutical packaging industry is investing millions in anti-counterfeiting products to safeguard pharma companies’ profits and protect patients from potentially lethal fakes. We profile some of the industry’s most promising recent innovations, including 2D codes, RFID advances and sophisticated tracking software.
Click here to read the full article.

Track & Protect
Anti-counterfeit packaging technologies are evolving as quickly as the black market for fake drugs grows. We profile some of the most promising systems used to identify, secure and track pharmaceutical products.
Click here to read the full article.

Take Your Medicine
Tassilo Korab, executive director of the Healthcare Compliance Packaging Council Europe, explains how packaging can play a key role in the crucial area of patient compliance.
Click here to read the full article.

Smart Packs
GSK’s principle packaging technologist Keith Allen explains the advances being made in smart packaging and how they are helping to ensure compliance among patients.
Click here to read the full article.

Next Issue Preview

Medical advances are leading to more new therapeutics but it is small biotech rather than Big Pharma which stands to gain the most. We meet the developers of promising medicines currently breaking into the market to find out whether it is time for the giants to move aside.

We also look at the Gates Foundation’s new collaboration for the research of new TB drugs, ask why Alzheimer’s researchers are turning back to previously discarded drugs, and find out if the discovery of an enzyme that gradually counteracts the efficacy of antipsychotic drugs could lead to the development of more effective schizophrenia treatment.

Moreover, we check in on the progress of major international research projects and investigate changing trends in early phase clinical trials.

Subscribe for free to get each future issue of Pharma Technology Focus delivered directly to your inbox.

Digital Magazine FAQ

The digital magazine is viewable on any computer with Flash Player installed. It is also viewable on mobile devices, iPhones and iPads, although some features and videos may be disabled.

Read the latest issue.

View the archive of back issues.